#Blood Transfusion Devices Market Growth
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
China blocked Tumblr because of pornography and censorship problems in 2013.
Text
Blood Purification Equipment Market Analysis, Size, Share, Growth, Trends, and Forecasts by 2031
The Global Blood Collection Devices market, within the healthcare sector, encompasses a diverse array of devices utilized for the collection and extraction of blood samples from individuals for diagnostic and therapeutic purposes.
𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.metastatinsight.com/request-sample/2627
Companies
Becton, Dickinson and Company (BD)
Terumo BCT
Fresenius Kabi AG
Grifols, S.A.
Nipro Medical Corporation
Greiner Holding AG
Quest Diagnostics Incorporated
Sarstedt AG & Co. KG
Macopharma
Haemonetics Corporation
Smiths Medical
Cardinal Health
Retractable Technologies, Inc.
Liuyang Sanli Medical Technology Development Co., Ltd.
FL Medical SRL
This industry plays an integral role in supporting various healthcare practices, including clinical diagnostics, blood transfusions, therapeutic drug monitoring, and disease monitoring. Blood collection devices facilitate the safe and efficient procurement of blood samples, ensuring accurate diagnosis and treatment for patients worldwide.
𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭:@https://www.metastatinsight.com/report/blood-collection-devices-market
One of the primary components of the blood collection devices market is the assortment of devices designed for venous blood collection. These devices, ranging from needles and syringes to vacuum tubes and lancets, are crucial for obtaining blood samples from veins for various medical procedures. Venous blood collection devices are meticulously engineered to minimize patient discomfort and reduce the risk of complications such as hematoma formation or nerve injury.
The global blood collection devices market is driven by several factors, including the increasing prevalence of chronic and infectious diseases, rising demand for blood transfusions, and growing awareness regarding the importance of early disease detection and monitoring. Furthermore, the expansion of healthcare infrastructure in emerging economies and the growing adoption of point-of care testing solutions are expected to fuel market growth in the coming years.
Despite the promising outlook, the blood collection devices market faces certain challenges, including stringent regulatory requirements, concerns regarding the safety and efficacy of blood collection devices, and the presence of alternative diagnostic technologies. Additionally, the high cost associated with advanced blood collection devices and the lack of skilled healthcare professionals proficient in blood collection techniques pose significant barriers to market growth in certain regions.
The Global Blood Collection Devices market is a dynamic and vital component of the healthcare industry, facilitating the collection of blood samples for diagnostic and therapeutic purposes. With ongoing technological innovation and increasing demand for healthcare services worldwide, the blood collection devices market is poised for continued growth and evolution in the years to come.
Global Blood Collection Devices market is estimated to reach $11061.1 Million by 2031; growing at a CAGR of 6.9% from 2024 to 2031.
Contact Us:
+1 214 613 5758
#BloodPurificationEquipment#BloodPurificationEquipmentmarket#BloodPurificationEquipmentindustry#marketsize#marketgrowth#marketforecast#marketanalysis#marketdemand#marketreport#marketresearch
0 notes
Text
Blood Collection Tubes For Liquid Biopsy Market Analysis, Size, Share, Growth, Trends, and Forecasts by 2031
The Global Blood Collection Devices market, within the healthcare sector, encompasses a diverse array of devices utilized for the collection and extraction of blood samples from individuals for diagnostic and therapeutic purposes.
𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.metastatinsight.com/request-sample/2627
Top Companies
Becton, Dickinson and Company (BD)
Terumo BCT
Fresenius Kabi AG
Grifols, S.A.
Nipro Medical Corporation
Greiner Holding AG
Quest Diagnostics Incorporated
Sarstedt AG & Co. KG
Macopharma
Haemonetics Corporation
Smiths Medical
Cardinal Health
Retractable Technologies, Inc.
Liuyang Sanli Medical Technology Development Co., Ltd.
FL Medical SRL
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭:@https://www.metastatinsight.com/report/blood-collection-devices-market/2627
This industry plays an integral role in supporting various healthcare practices, including clinical diagnostics, blood transfusions, therapeutic drug monitoring, and disease monitoring. Blood collection devices facilitate the safe and efficient procurement of blood samples, ensuring accurate diagnosis and treatment for patients worldwide.
The global blood collection devices market is driven by several factors, including the increasing prevalence of chronic and infectious diseases, rising demand for blood transfusions, and growing awareness regarding the importance of early disease detection and monitoring. Furthermore, the expansion of healthcare infrastructure in emerging economies and the growing adoption of point-of care testing solutions are expected to fuel market growth in the coming years.
Despite the promising outlook, the blood collection devices market faces certain challenges, including stringent regulatory requirements, concerns regarding the safety and efficacy of blood collection devices, and the presence of alternative diagnostic technologies. Additionally, the high cost associated with advanced blood collection devices and the lack of skilled healthcare professionals proficient in blood collection techniques pose significant barriers to market growth in certain regions.
The Global Blood Collection Devices market is a dynamic and vital component of the healthcare industry, facilitating the collection of blood samples for diagnostic and therapeutic purposes. With ongoing technological innovation and increasing demand for healthcare services worldwide, the blood collection devices market is poised for continued growth and evolution in the years to come.
Global Blood Collection Devices market is estimated to reach $11061.1 Million by 2031; growing at a CAGR of 6.9% from 2024 to 2031.
Contact Us:
+1 214 613 5758
#BloodCollectionTubesForLiquidBiopsy#BloodCollectionTubesForLiquidBiopsymarket#BloodCollectionTubesForLiquidBiopsyindustry#marketsize#marketgrowth#marketforecast#marketanalysis#marketdemand#marketreport#marketresearch
0 notes
Text
Blood Bank Equipment Manufacturers In Gurugram
Gurugram, a leading industrial hub in India, is home to a growing number of manufacturers specializing in blood bank equipment. These companies play a crucial role in ensuring the availability of safe blood for medical use by designing, producing, and supplying advanced technologies that streamline the blood donation, storage, and transfusion processes.
Key Equipment Manufactured
Blood bank equipment is integral to maintaining blood safety and quality. The main types of equipment produced include:
Blood Collection Devices: These devices are designed to ensure safe, efficient blood collection. They include blood bags, needles, and collection sets that minimize contamination risks and enhance donor comfort.
Blood Storage Systems: Manufacturers produce refrigerators, freezers, and blood storage cabinets that maintain the optimal temperature for preserving blood products such as whole blood, red blood cells, platelets, and plasma.
Blood Bank Centrifuges: Used for separating components of blood, centrifuges are crucial for separating plasma, platelets, and red blood cells. They ensure efficient processing and storage of blood products.
Blood Bank Analyzers: These advanced devices help in testing blood for compatibility, blood type, and screening for infections. They play a vital role in ensuring the safety of transfusions.
Blood Warmers: Used to safely warm blood before transfusion, these devices are essential for preventing hypothermic complications during critical procedures.
Sterilization Equipment: Ensuring the sterilization of blood collection kits and storage containers is vital for maintaining a sterile environment and preventing infections.
The Importance of Advanced Technology in Blood Banking
The healthcare industry is continuously evolving, and blood banks are no exception. The equipment used in blood banks must comply with rigorous standards for safety, precision, and efficiency. Manufacturers in Gurugram focus on creating cutting-edge technologies that improve the overall performance and safety of blood banks.
Automation and Integration: Automation has revolutionized the blood bank industry by streamlining workflows, reducing human error, and improving efficiency. Manufacturers are increasingly integrating advanced IT solutions, allowing for real-time tracking of blood supplies and enhancing inventory management.
Quality Control: Blood banks rely on equipment that can withstand regular use while maintaining the highest standards of performance. Manufacturers in Gurugram adhere to strict quality control procedures to ensure the longevity and accuracy of their products.
Market Demand and Growth
The demand for blood bank equipment in India, particularly in Gurugram, is growing due to the expansion of healthcare facilities, both public and private. The increase in surgeries, trauma care, and cancer treatments has contributed to a heightened need for blood products, which directly impacts the demand for reliable and efficient equipment.
In addition to the domestic market, manufacturers in Gurugram also export their products internationally, making India an important player in the global blood bank equipment industry.
Conclusion
Blood bank equipment manufacturers in Gurugram are at the forefront of providing essential technologies that support healthcare systems and blood transfusion services. By combining innovation, quality, and adherence to international standards, these manufacturers contribute significantly to the availability of safe and effective blood products, ultimately saving lives.
Blood Bank Equipment Manufacturers In Gurugram
0 notes
Text
Revealing Phlebotomy Statistics: Key Insights on Trends, Growth, and Career Opportunities
Unveiling Phlebotomy statistics: Key Insights on Trends, Growth, and Career Opportunities
The field of phlebotomy plays a critical role in modern healthcare. With the rise in demand for medical services and laboratory tests, understanding the dynamics of phlebotomy can provide both aspiring professionals and industry stakeholders with vital insights. In this article, we will explore the latest phlebotomy statistics, trends, growth projections, and the career opportunities that lie ahead for those considering a path in this vital healthcare role.
Understanding Phlebotomy
Phlebotomy is the practice of drawing blood for clinical or medical testing, transfusions, research, or blood donations. Trained professionals known as phlebotomists are the frontline workers ensuring samples are collected safely and efficiently.
Current Phlebotomy Statistics
Employment Growth Trends
The U.S. Bureau of Labor Statistics (BLS) reports a promising outlook for phlebotomists. As of 2023, the employment of phlebotomists is projected to grow by 22% from 2020 to 2030, much faster than the average for all occupations. This growth is underscored by several key factors:
Increasing older population requiring lab testing.
advancements in medical technology needing a greater need for phlebotomy services.
Expansion of healthcare facilities and outpatient services.
Salary Expectations
The average annual salary for phlebotomists in the United States ranges from $36,000 to $50,000, depending significantly on experience, location, and the healthcare setting. Here’s a breakdown of average salaries by state:
State
Average salary
California
$52,000
Texas
$42,000
Florida
$39,000
New York
$48,000
Ohio
$36,500
Trends Shaping the Future of Phlebotomy
technological Advancements
Emerging technologies are revolutionizing how blood draws are conducted. Innovations such as:
Automated blood collection devices
Mobile phlebotomy services
Telehealth integration for remote patient monitoring
are making the process more efficient and less invasive. Awareness of these technologies is vital for new phlebotomists to stay competitive in the job market.
Increased Emphasis on Certification
With the growing complexity of laboratory procedures, there is an increased emphasis on certification. Many employers are looking for candidates who are:
CERTIFIED NATIONAL PHLEBOTOMY TECHNICIANS (CPT)
CERTIFIED PHLEBOTOMY TECHNICIANS (CPT) by NHA
Eligible for state certifications as defined by local regulations
Benefits of a Career in Phlebotomy
Choosing a career in phlebotomy offers numerous benefits, including:
Job security: With a rapidly aging population, the need for skilled phlebotomists is guaranteed.
Flexible Work Habitat: Phlebotomists can work in hospitals, clinics, laboratories, and even in-home care settings.
Fulfillment: Helping patients and contributing to health outcomes can be incredibly rewarding.
Career Opportunities for Phlebotomists
The growing demand for phlebotomists opens numerous career pathways, including:
Clinical Laboratory Phlebotomist: Works in laboratories focusing on blood draws and testing.
Donor Phlebotomist: Engages with blood donation centers, ensuring donor safety and care.
Pediatric Phlebotomist: Specializes in drawing blood from children, requiring specialized training.
Mobile Phlebotomist: Travels to various locations for blood draws, offering flexible work hours.
Practical Tips for Aspiring Phlebotomists
If you’re considering a career in phlebotomy,here are some practical tips:
Gain experience through internships or volunteer at local clinics or hospitals.
Stay updated on industry trends and advancements through continued education.
Network with professionals in the field to explore job opportunities.
Real-World Case Studies
Case studies provide valuable insights into the impacts of phlebotomy on patient care. For instance,a 2022 study in a prominent hospital demonstrated that implementing mobile phlebotomy services reduced wait times for blood draws by 30%,improving patient satisfaction rates significantly.
Conclusion
The field of phlebotomy is vibrant and full of opportunities, characterized by rapid growth and technological advancements. As the demand for phlebotomists continues to rise, it is essential for aspiring professionals to stay informed and upskill continuously. By understanding the latest trends, embracing technology, and pursuing appropriate certifications, individuals can thrive in this rewarding career. If you’re passionate about contributing to healthcare, a career in phlebotomy might just be the right path for you!
youtube
https://phlebotomytrainingcenter.net/revealing-phlebotomy-statistics-key-insights-on-trends-growth-and-career-opportunities/
0 notes
Link
0 notes
Text
Leukapheresis Market to Grow: $3.5B in 2023 to $7.8B by 2033 (8.1% CAGR)
Leukapheresis Market focuses on the extraction and collection of leukocytes (white blood cells) from blood for therapeutic, research, and clinical applications. It includes a range of devices, consumables, and services that support the separation and processing of these cells. This market plays a crucial role in advancements in immunotherapy, cell-based therapies, and personalized medicine, addressing the increasing demand for innovative treatments and research-driven applications.
To Request Sample Report: https://www.globalinsightservices.com/request-sample/?id=GIS10318 &utm_source=SnehaPatil&utm_medium=Article
Market Growth & Trends
The Leukapheresis Market is experiencing substantial growth, primarily driven by the rising demand for personalized medicine and the growing prevalence of conditions such as leukemia and autoimmune disorders. Disposable leukapheresis devices lead the market, favored for their convenience, reduced risk of contamination, and cost-effectiveness. Leukapheresis devices follow closely, supported by continuous technological innovations that improve the efficiency, safety, and patient comfort of these procedures. In terms of applications, research applications dominate, fueled by the increased focus on cell-based therapies, cancer research, and immunotherapy advancements. Therapeutic leukapheresis comes as the second-highest performing segment, driven by expanding clinical trials and approvals for novel therapies.
Regional Insights
North America leads the market, attributed to its advanced healthcare infrastructure, substantial investment in research and development, and a strong focus on personalized medicine.
Europe follows as the second-largest market, with robust government support for biotechnology research and increasing demand for cutting-edge medical treatments.
The Asia-Pacific region is experiencing rapid growth, driven by increasing healthcare expenditure, rising awareness of advanced treatment options, and an expanding patient base.
Market Segmentation
By Type:
Therapeutic Leukapheresis
Donor Leukapheresis
Research Leukapheresis
By Product:
Apheresis Devices
Apheresis Disposables
Leukoreduction Filters
By Services:
Leukapheresis Procedure Services
Leukapheresis Data Management Services
Patient Support Services
By Technology:
Centrifugation
Membrane Filtration
By Component:
White Blood Cells
Stem Cells
By Application:
Hematologic Diseases
Research Applications
Cancer Treatment
By End User:
Hospitals
Blood Donation Centers
Research Institutes
Biopharmaceutical Companies
By Process:
Manual Leukapheresis
Automated Leukapheresis
By Equipment:
Leukapheresis Machines
Blood Bag Sets
By Mode:
Inpatient
Outpatient
Market Volume & Projections
In 2023, the Leukapheresis Market exhibited a robust volume of approximately 320 million procedures globally, with projections indicating it will reach 500 million procedures by 2033. The therapeutic leukapheresis segment holds the largest share of the market at 55%, due to its essential role in treating hematologic malignancies such as leukemia. Research applications follow with a 30% market share, driven by the growing focus on immunotherapy and other novel cancer treatments. The donor leukapheresis segment accounts for the remaining 15%, crucial for the donation and transfusion of blood components.
Key Market Players
Key players shaping the Leukapheresis Market include Fresenius Kabi, Terumo BCT, Haemonetics Corporation, and Gambro. These companies continue to drive the market with technological advancements, product innovations, and strategic partnerships that enhance their market position in the rapidly expanding leukapheresis space.
#Leukapheresis #CellTherapies #Immunotherapy #PersonalizedMedicine #LeukemiaTreatment #CancerResearch #BloodDonation #ApheresisDevices #HealthcareInnovation #MedicalResearch #BiotechResearch #TherapeuticApheresis #ResearchApplications #MedicalDevices #HematologicDiseases #BloodComponents
0 notes
Text
Empowering Healthcare Providers with Precision Blood Screening Tools
Blood Screening Industry Overview
The global blood screening market size is expected to reach USD 6.62 billion by 2030, registering a CAGR of 11.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the increase in screening of donor and continuous technological advancement by the market players. Demand for blood screening tests is increasing continuously due to increasing donation, rising awareness about transfusion-transmitted diseases, and technological developments in the industry. Furthermore, governments of various countries are in process to mandates testing all donated blood for several viruses.
Thorough screening is necessary for all donated blood to ensure that recipients receive the safest products. As of 2015, such testing consists of screening for red cell antibodies, and the infectious diseases agents: HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum (syphilis). The result of all these assays must be negative for blood donation.
Gather more insights about the market drivers, restrains and growth of the Blood Screening Market
Technological developments increase the sensitivity and efficiency of the tests. For instance, in 2016, the U.S. FDA approved the Procleix Zika virus assay from Hologic, Inc. and Grifols to screen donated blood. Furthermore, the U.S. FDA approved next-generation sequencing (NGS) technology in 2013. The technology is cheaper and faster than previous DNA analysis methods.
Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.
The global body fluid collection and diagnostics market size was estimated at USD 34.35 billion in 2024 and is projected to grow at a CAGR of 6.6% from 2025 to 2030.
The global genetic testing market size was estimated at USD 11.71 billion in 2024 and is projected to grow at a CAGR of 22.5% from 2025 to 2030.
Blood Screening Market Segmentation
Grand View Research has segmented global blood screening market report based on technology, product, and region:
Blood Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
Nucleic Acid Amplification Test (NAT)
ELISA
Chemiluminescence Immunoassay (CLIA & EIA )
Next Generation Sequencing (NGS)
Western Blotting (WB)
Blood Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
Reagent
Instrument
Blood Screening Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
US
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
India
Japan
China
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
Saudi Arabia
South Africa
UAE
Kuwait
Key Companies profiled:
Abbott
Danaher Corporation (Beckman Coulter)
Becton Dickinson and Company
Bio-Rad Laboratories, Inc.
Hoffman-La Roche Ltd.
Grifols, S.A.
Ortho-Clinical Diagnostics, Inc.
Siemens Healthcare GmbH
Thermo Fisher Scientific, Inc.
SOFINA s.a (Biomerieux)
Key Blood Screening Company Insights
Some of the key companies in the market include Bio-Rad Laboratories, Inc., Hoffman-La Roche Ltd., Grifols, S.A., and others. These companies adopt strategies such as strategic collaborations to enhance innovation, mergers, and acquisitions to expand capabilities, and new product launches to address evolving healthcare needs, ensuring competitiveness and a strong market presence.
Abbott manufactures specialized medical equipment that may utilize Blood Screening components for durability and lightweight properties. Beyond blood screening, Abbott operates in various segments, including laboratory diagnostics, cardiovascular devices, diabetes care, and nutrition products, thereby enhancing its portfolio and addressing diverse healthcare needs.
Bio-Rad Laboratories, Inc. develops diagnostic instruments that may incorporate Blood Screening materials for enhanced performance and reliability in relation to Blood Screening. The company also engages in other segments, such as quality control products, gene expression analysis, and protein purification, positioning itself as a leader in both research and clinical settings.
Recent Developments
In May 2023, Siemens Healthineers launched two new analyzers, the Atellica HEMA 570 and Atellica HEMA 580, designed for high-volume hematology testing, crucial for blood screening. These advanced devices can streamline the complete blood count (CBC) process, offering rapid results and improved workflow efficiency. With the ability to process up to 120 tests per hour, these analyzers can address the growing demand for timely diagnostics in critical care settings.
Order a free sample PDF of the Blood Screening Market Intelligence Study, published by Grand View Research.
0 notes
Text
Blood Screening Market Size, Share & Trends Analysis Report By 2030
The global blood screening market was valued at USD 3.40 billion in 2024, and it is expected to grow at a compound annual growth rate (CAGR) of 11.9% from 2025 to 2030. The market's rapid expansion is primarily driven by the increasing number of blood donations worldwide, which necessitates stringent screening protocols to ensure the safety of blood and detect transfusion-transmissible infections. This growth is further fueled by advancements in technology, particularly in automation and molecular platforms, which enhance the accuracy and efficiency of blood screening processes. Additionally, the rising prevalence of infectious diseases, combined with government initiatives aimed at promoting blood safety, is contributing to the market's upward trajectory. Growing public awareness about the importance of safe blood transfusions also plays a key role in market growth.
Blood screening is a critical medical procedure that involves analyzing blood samples to detect various health conditions and abnormalities. It provides vital insights into an individual's health, allowing for the early detection, prevention, and management of diseases. The screening process typically involves evaluating blood cell counts, identifying infectious agents like viruses and bacteria, and measuring levels of chemicals such as cholesterol and glucose. The significance of blood screening lies in its ability to help healthcare professionals identify potential health problems before symptoms appear. This is crucial in diagnosing conditions like anemia, diabetes, infections, and cardiovascular diseases.
Gather more insights about the market drivers, restrains and growth of the Blood Screening Market
Technological advancements continue to improve the precision and efficiency of blood screening methods. At the same time, increasing awareness about the importance of early disease detection promotes the adoption of preventive healthcare measures. Another contributing factor to the market's growth is the aging global population, which is associated with a higher prevalence of diseases that require blood screening. Rising healthcare expenditures around the world also support the adoption of advanced technologies and services in the blood screening field. Together, these factors drive the ongoing growth and evolution of the blood screening market, highlighting its essential role in proactive healthcare strategies aimed at improving patient outcomes and public health.
Product Segmentation Insights:
In 2024, reagents led the blood screening market, accounting for the largest revenue share of 73.4%. Reagents are critical components in diagnostic tests, providing the chemical, biological, or immunological substances required to trigger specific reactions that yield accurate test results. The growing demand for highly specific and precise blood analyses has driven the development of innovative reagent formulations that enhance the performance of diagnostic tests. Reagents are also cost-effective, making them widely accessible, which contributes to their dominant market position.
The instruments segment is expected to experience the fastest growth, with a projected CAGR of 10.8% over the forecast period. This growth is attributed to technological advancements and the increasing demand for reliable diagnostic solutions. Modern blood screening instruments are designed to improve both accuracy and efficiency, addressing the need for rapid diagnostics in healthcare settings. Innovations such as high-throughput analyzers and point-of-care testing devices have improved the usability and accessibility of blood testing. Despite challenges such as high costs and the reusable nature of some devices, continuous technological development is expected to drive sustained growth in this segment. Healthcare providers are increasingly seeking dependable and efficient tools for blood analysis, and the advancements in instruments are expected to meet these evolving needs.
In summary, the global blood screening market is poised for strong growth due to factors such as increasing blood donations, technological innovations, rising healthcare expenditures, and greater public awareness. The market will continue to evolve, driven by a combination of product developments in reagents and instruments, along with a growing focus on preventive healthcare and early disease detection.
Order a free sample PDF of the Blood Screening Market Intelligence Study, published by Grand View Research.
#Blood Screening Market Forecast#Blood Screening Market Overview#Blood Screening Market Size#Blood Screening Industry
0 notes
Text
Blood Screening Industry Size & Share | Statistics Report 2030
The global blood screening market was valued at USD 3.40 billion in 2024, and it is expected to grow at a compound annual growth rate (CAGR) of 11.9% from 2025 to 2030. The market's rapid expansion is primarily driven by the increasing number of blood donations worldwide, which necessitates stringent screening protocols to ensure the safety of blood and detect transfusion-transmissible infections. This growth is further fueled by advancements in technology, particularly in automation and molecular platforms, which enhance the accuracy and efficiency of blood screening processes. Additionally, the rising prevalence of infectious diseases, combined with government initiatives aimed at promoting blood safety, is contributing to the market's upward trajectory. Growing public awareness about the importance of safe blood transfusions also plays a key role in market growth.
Blood screening is a critical medical procedure that involves analyzing blood samples to detect various health conditions and abnormalities. It provides vital insights into an individual's health, allowing for the early detection, prevention, and management of diseases. The screening process typically involves evaluating blood cell counts, identifying infectious agents like viruses and bacteria, and measuring levels of chemicals such as cholesterol and glucose. The significance of blood screening lies in its ability to help healthcare professionals identify potential health problems before symptoms appear. This is crucial in diagnosing conditions like anemia, diabetes, infections, and cardiovascular diseases.
Gather more insights about the market drivers, restrains and growth of the Blood Screening Market
Technological advancements continue to improve the precision and efficiency of blood screening methods. At the same time, increasing awareness about the importance of early disease detection promotes the adoption of preventive healthcare measures. Another contributing factor to the market's growth is the aging global population, which is associated with a higher prevalence of diseases that require blood screening. Rising healthcare expenditures around the world also support the adoption of advanced technologies and services in the blood screening field. Together, these factors drive the ongoing growth and evolution of the blood screening market, highlighting its essential role in proactive healthcare strategies aimed at improving patient outcomes and public health.
Product Segmentation Insights:
In 2024, reagents led the blood screening market, accounting for the largest revenue share of 73.4%. Reagents are critical components in diagnostic tests, providing the chemical, biological, or immunological substances required to trigger specific reactions that yield accurate test results. The growing demand for highly specific and precise blood analyses has driven the development of innovative reagent formulations that enhance the performance of diagnostic tests. Reagents are also cost-effective, making them widely accessible, which contributes to their dominant market position.
The instruments segment is expected to experience the fastest growth, with a projected CAGR of 10.8% over the forecast period. This growth is attributed to technological advancements and the increasing demand for reliable diagnostic solutions. Modern blood screening instruments are designed to improve both accuracy and efficiency, addressing the need for rapid diagnostics in healthcare settings. Innovations such as high-throughput analyzers and point-of-care testing devices have improved the usability and accessibility of blood testing. Despite challenges such as high costs and the reusable nature of some devices, continuous technological development is expected to drive sustained growth in this segment. Healthcare providers are increasingly seeking dependable and efficient tools for blood analysis, and the advancements in instruments are expected to meet these evolving needs.
In summary, the global blood screening market is poised for strong growth due to factors such as increasing blood donations, technological innovations, rising healthcare expenditures, and greater public awareness. The market will continue to evolve, driven by a combination of product developments in reagents and instruments, along with a growing focus on preventive healthcare and early disease detection.
Order a free sample PDF of the Blood Screening Market Intelligence Study, published by Grand View Research.
#Blood Screening Market Forecast#Blood Screening Market Overview#Blood Screening Market Size#Blood Screening Industry
0 notes
Text
Global Blood Market Analysis 2024: Size Forecast and Growth Prospects
The blood global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Blood Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size - The blood market size has grown strongly in recent years. It will grow from $7.83 billion in 2023 to $8.32 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to the surge in demand for blood and plasma, an increase in the number of surgeries, a growing global population, increasing incidence of chronic diseases, rising number of blood banks.
The blood market size is expected to see strong growth in the next few years. It will grow to $10.62 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to favorable government regulations, a rise in the geriatric population, rising awareness about blood donation, increase in blood transfusion, increasing number of ambulatory surgical centers (ASCS). Major trends in the forecast period include advancements in blood transfusion and blood screening instruments, computerized immunoassays, smart blood bank inventory control systems, technological innovations, precise temperature monitoring and control.
Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/blood-global-market-report
Scope Of Blood Market The Business Research Company's reports encompass a wide range of information, including:
Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
Drivers: Examination of the key factors propelling market growth.
Trends: Identification of emerging trends and patterns shaping the market landscape.
Key Segments: Breakdown of the market into its primary segments and their respective performance.
Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
Macro Economic Factors: Assessment of broader economic elements impacting the market.
Blood Market Overview
Market Drivers - The increase in the number of surgeries is expected to propel the growth of the blood market. The rise in the number of surgeries is driven by improvements in medical technology, an aging demographic, and more chronic disease cases. Blood is essential in surgery to supply oxygen and nutrients, aiding clotting to control bleeding and enhance the immune response to combat infections. For instance, in December 2023, according to the Australian Institute of Health and Welfare, an Australia-based government administration, in 2022–2023, 735,500 patients were admitted for surgery from public hospital elective surgery waiting lists, marking an 18% rise compared to 2021–2022. Therefore, the increase in the number of surgeries is driving the blood market going forward.
Market Trends - Major companies operating in the blood market are developing advanced blood transfusion instruments, such as plasma collection systems, to improve efficiency, enhance donor safety, and increase the overall quality of blood products. A plasma collection system is a device that extracts plasma from a donor's blood by separating it from other components and returning the rest to the donor through plasmapheresis. For instance, in March 2022, Terumo Blood and Cell Technologies, a US-based blood component and cellular technology company, received Food and Drug Administration approval for the Rika Plasma Donation System (Rika). It is a next-generation plasma collection system that focuses on improving the experience for plasma center employees and donors, featuring safety measures to reduce operator errors and completing plasma collection in 35 minutes or less. Rika ensures no more than 200 milliliters of blood are outside the donor's body at any time and includes an advanced control system for operators.
The blood market covered in this report is segmented –
1) By Product: Whole Blood Collection And Processing, Source Plasma Collection, Blood Typing Products, Blood Screening Products 2) By Mode of Delivery: Infusion Solutions, Gels, Sprays, Biomedical Sealants 3) By End User: Blood And Blood Component Bank, Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals, Other End Users
Get an inside scoop of the blood market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=18265&type=smp
Regional Insights - North America was the largest region in the blood market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies - Major companies operating in the blood market are Cardinal Health Inc., Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic Plc, Danaher Corp., Merck KGaA, Asahi Kasei Medical Co. Ltd., Henry Schein Inc., Medline Industries Inc., B. Braun Melsungen AG, Grifols SA, Terumo Corp., Nipro Corp., QuidelOrtho Corp., Bio Rad Laboratories Inc., LivaNova PLC, Haemonetics Corp., Macopharma, DIAGAST SAS, BAG Health Care GmbH, Kawasumi Laboratories America Inc
Table of Contents
Executive Summary
Blood Market Report Structure
Blood Market Trends And Strategies
Blood Market – Macro Economic Scenario
Blood Market Size And Growth …..
Blood Market Competitor Landscape And Company Profiles
Key Mergers And Acquisitions
Future Outlook and Potential Analysis
Appendix
Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: [email protected]
Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
0 notes
Text
Blood Screening Market Outlook and Forecast Report, 2030
The global blood screening market is expected to reach USD 6.62 billion by 2030, registering a CAGR of 11.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the increase in screening of donor and continuous technological advancement by the market players. Demand for blood screening tests is increasing continuously due to increasing donation, rising awareness about transfusion-transmitted diseases, and technological developments in the industry. Furthermore, governments of various countries are in process to mandates testing all donated blood for several viruses.
Thorough screening is necessary for all donated blood to ensure that recipients receive the safest products. As of 2015, such testing consists of screening for red cell antibodies, and the infectious diseases agents: HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum (syphilis). The result of all these assays must be negative for blood donation.
Technological developments increase the sensitivity and efficiency of the tests. For instance, in 2016, the U.S. FDA approved the Procleix Zika virus assay from Hologic, Inc. and Grifols to screen donated blood. Furthermore, the U.S. FDA approved next-generation sequencing (NGS) technology in 2013. The technology is cheaper and faster than previous DNA analysis methods.
Gather more insights about the market drivers, restrains and growth of the Blood Screening Market
Detailed Segmentation:
Product Insights
On the basis of product, the market is segmented into instruments and reagents. The reagent segment accounted for the largest revenue share of around 73.0% in 2022 and is expected to grow at the fastest CAGR of 12.0% over the forecast period owing to higher accuracy and specificity in detecting the presence and type of various elements in a small sample would drive the market.
Technology Insights
On the basis of technology, the market is segmented into nucleic acid amplification tests, ELISA, CLIA, EIA, NGS, and western blotting. The NAT segment accounted for the largest revenue share of 41.8% in 2022, owing to its high sensitivity and specificity for viral nucleic acid. The test detects nucleic acid earlier than other screening methods and, thus, narrows the window period of HBV, HCV, and HIV. According to the WHO, HIV has claimed 40.1 million lives till now and remains a global health concern with the current transmission in all countries where 1.5 million people attained HIV in 2021.
Regional Insights
North America dominated the market and accounted for the largest revenue share of 39.0% in 2022 owing to the presence of key industry players, increased adoption of the blood screening process, stringent FDA regulations for transfusion, rising infectious disease prevalence, and greater patient affordability are responsible for maintaining its position during the forecast period. The U.S. leads the market due to the local presence of leading players such as Roche Diagnostics, Abbott, and Danaher. One of the reasons for their continued dominance is the presence of well-established R&D infrastructure and favorable reimbursement policies.
Browse through Grand View Research's Medical Devices Industry Research Reports.
• The global electron microscopes market size was valued at USD 5.05 billion in 2023 and is projected to grow at a CAGR of 8.1% from 2024 to 2030.
• The global ambient assisted living market size was valued at USD 7.36 billion in 2023 and is projected to grow at a CAGR of 26.8% from 2024 to 2030. .
Key Companies & Market Share Insights
Product launches, approvals, strategic acquisitions, and innovations are just a few of the important business strategies used by market participants to maintain and grow their global reach.
For instance, in March 2023,Abbott received U.S Food and Drug Administration (FDA) clearance for a laboratory traumatic brain injury blood test, the first commercially available lab-based test for the assessment of mild traumatic brain injuries (TBIs), commonly referred to as concussions, which will be made widely available to hospitals across the U.S. This test, which is powered by Abbott’s Alinity i laboratory tool, will enable clinicians to evaluate individuals with mild traumatic brain injuries in a timely manner.
Furthermore, in May 2023, Siemens Healthcare introduced Atellica HEMA 570 and 580 next-generation hematology analyzers, which have user-friendly interfaces and can be connected to multiple analyzers to remove workflow barriers and provide high throughput time.
Key Blood Screening Companies:
• Abbott
• Danaher Corporation (Beckman Coulter)
• Becton Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Hoffman-La Roche Ltd.
• Grifols, S.A.
• Ortho-Clinical Diagnostics, Inc.
• Siemens Healthcare GmbH
• Thermo Fisher Scientific, Inc.
• SOFINA s.a (Biomerieux)
Blood Screening Market Segmentation
Grand View Research has segmented the blood screening market by product, technology, and region:
Blood Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
• Nucleic Acid Amplification Test (NAT)
• ELISA
• Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
• Next Generation Sequencing
• Western Blotting
Blood Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
• Reagent
• Instrument
Blood Screening Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
o U.S.
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Sweden
o Norway
o Denmark
• Asia Pacific
o Japan
o China
o India
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East and Africa
o Saudi Arabia
o South Africa
o UAE
o Kuwait
Order a free sample PDF of the Blood Screening Market Intelligence Study, published by Grand View Research.
#Blood Screening Market#Blood Screening Market size#Blood Screening Market share#Blood Screening Market analysis#Blood Screening Industry
0 notes
Text
Future of Medical Tubing Industry
The report "Medical Tubing Market by Material (Plastics, Rubbers, Specialty Polymers), Application (Bulk Disposable Tubing, Catheters & Cannulas, Drug Delivery Systems, Specialty Applications), Structure, and Region - Global Forecast to 2028", is projected to reach USD 15.7 billion by 2028, at a CAGR of 8.2% from USD 10.6 billion in 2023.
Download PDF Brochure at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162082103
Browse 218 market data Tables and 40 Figures spread through 249 Pages and in-depth TOC on "Medical Tubing Market by Material (Plastics, Rubbers, Specialty Polymers), Application (Bulk Disposable Tubing, Catheters & Cannulas, Drug Delivery Systems, Specialty Applications), Structure, and Region - Global Forecast to 2028" View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/medical-tubing-market-162082103.html
The Medical tubing market is driven by increasing demand for minimally invasive medical procedures, growing adoption of advanced medical technologies, development of novel technology, increasing demand for medical tubing in healthcare industry, and stringent regulations for medical devices.
“Rubber is projected to be the largest material of medical tubing, in terms of value, during the forecast period.”
Rubber medical tubing is made from different materials such as silicone, polyurethane, latex, thermoplastic elastomer, ethylene propylene diene monomer, and thermoplastic polyurethane. These tubes are flexible, durable, and abrasion-resistant, making it suitable for various medical applications. It is used for various applications such as blood transfusion, IV transfusion tubing, respiratory tubing, urological products, syringes, needles, surgical instruments, and others.
“Catheters & cannulas is projected to be the largest application of the medical tubing, in terms of value.”
Catheters & cannulas are medical tubes used for healthcare applications such as medication, drainages of fluids, and blood pressure measurement. The catheters & cannulas market is driven by increasing cardiovascular diseases and the growing demand for minimally invasive surgeries. Consumers are opting for minimally invasive surgeries, as the procedure reduces the time of stay in hospitals during treatment, which lowers the overall costs a patient will incur during the treatment.
Request For FREE Sample of Report at https://www.marketsandmarkets.com/requestsampleNew.asp?id=162082103
“North America captures the largest share in the medical tubing market during the forecast period, in terms of value.”
The North America region is a significant market for medical tubing, driven by high awareness of medical tubing for applications such as bulk disposable tubing, catheters & cannulas, drug delivery devices, special applications in the healthcare sector, and large-scale production in the region, technological advancements, aging population, and stringent regulatory standards.
Mergers, new product launches and expansions are the major growth strategies adopted by the key players in the market. The key global players in the medical tubing market include Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), Lubrizol Corporation (US), TE Connectivity (Switzerland), Nordson Corporation (US), Elkem ASA (Norway), Raumedic AG (Germany), Teknor Apex (US), and Spectrum Plastics Group (US).
Don’t miss out on business opportunities in Medical Tubing Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
1 note
·
View note
Text
Blood Collection Devices Market Analysis, Size, Share, Growth, Trends, and Forecasts by 2031
The Global Blood Collection Devices market, within the healthcare sector, encompasses a diverse array of devices utilized for the collection and extraction of blood samples from individuals for diagnostic and therapeutic purposes.
𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.metastatinsight.com/request-sample/2627
Top Companies
Becton, Dickinson and Company (BD)
Terumo BCT
Fresenius Kabi AG
Grifols, S.A.
Nipro Medical Corporation
Greiner Holding AG
Quest Diagnostics Incorporated
Sarstedt AG & Co. KG
Macopharma
Haemonetics Corporation
Smiths Medical
Cardinal Health
Retractable Technologies, Inc.
Liuyang Sanli Medical Technology Development Co., Ltd.
FL Medical SRL
This industry plays an integral role in supporting various healthcare practices, including clinical diagnostics, blood transfusions, therapeutic drug monitoring, and disease monitoring. Blood collection devices facilitate the safe and efficient procurement of blood samples, ensuring accurate diagnosis and treatment for patients worldwide.
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭:@https://www.metastatinsight.com/report/blood-collection-devices-market/2627
One of the primary components of the blood collection devices market is the assortment of devices designed for venous blood collection. These devices, ranging from needles and syringes to vacuum tubes and lancets, are crucial for obtaining blood samples from veins for various medical procedures. Venous blood collection devices are meticulously engineered to minimize patient discomfort and reduce the risk of complications such as hematoma formation or nerve injury.
Despite the promising outlook, the blood collection devices market faces certain challenges, including stringent regulatory requirements, concerns regarding the safety and efficacy of blood collection devices, and the presence of alternative diagnostic technologies. Additionally, the high cost associated with advanced blood collection devices and the lack of skilled healthcare professionals proficient in blood collection techniques pose significant barriers to market growth in certain regions.
The Global Blood Collection Devices market is a dynamic and vital component of the healthcare industry, facilitating the collection of blood samples for diagnostic and therapeutic purposes. With ongoing technological innovation and increasing demand for healthcare services worldwide, the blood collection devices market is poised for continued growth and evolution in the years to come.
Global Blood Collection Devices market is estimated to reach $11061.1 Million by 2031; growing at a CAGR of 6.9% from 2024 to 2031.
Contact Us:
+1 214 613 5758
#BloodCollectionDevices#BloodCollectionDevicesmarket#BloodCollectionDevicesindustry#marketsize#marketgrowth#marketforecast#marketanalysis#marketdemand#marketreport#marketresearch
0 notes
Text
Blood Bank Equipment Manufacturers In Noida
Greater Noida, a thriving hub of industrial and technological advancements in India, has become a prominent location for healthcare equipment manufacturing. Among the notable players in the region, LifeSaver Inc. Group stands out as a leading manufacturer of blood bank equipment, offering cutting-edge solutions for the medical and healthcare sectors.
The Importance of Blood Bank Equipment
Blood banks play a crucial role in healthcare systems by ensuring the availability of safe and tested blood and its components for transfusions. The efficiency and reliability of blood banks heavily depend on the quality of equipment they use. From blood storage refrigerators to centrifuges and blood collection monitors, these devices ensure that blood and its derivatives are processed, stored, and utilized effectively and safely.
LifeSaver Inc. Group: Pioneering Excellence
LifeSaver Inc. Group has established itself as a trusted name in the manufacturing of high-quality blood bank equipment. With a commitment to innovation and excellence, the company has become a preferred choice for hospitals, diagnostic centers, and blood banks across the region.
Product Offerings: LifeSaver Inc. Group provides a comprehensive range of blood bank equipment, including:
Blood Storage Refrigerators: Designed to maintain precise temperatures for safe blood storage, these refrigerators come equipped with advanced digital control systems.
Plasma Freezers: Ensuring the long-term preservation of plasma, these freezers adhere to stringent medical standards.
Blood Collection Monitors: Essential for accurate and safe blood collection, these monitors feature user-friendly designs and robust functionality.
Centrifuges: High-speed centrifuges for separating blood components efficiently and reliably.
Platelet Agitators and Incubators: Ensuring the proper storage and viability of platelets for transfusions.
Quality and Standards: LifeSaver Inc. Group prioritizes quality, ensuring that its products meet international standards such as ISO and CE certifications. The company’s state-of-the-art manufacturing facility in Greater Noida is equipped with advanced technology and follows rigorous quality control processes.
Customer-Centric Approach: What sets LifeSaver Inc. Group apart is its customer-focused philosophy. The company offers:
Customization: Tailored solutions to meet specific requirements of healthcare facilities.
After-Sales Support: Comprehensive maintenance and support services to ensure uninterrupted operation of equipment.
Training and Consultation: Assisting clients in understanding the operational and technical aspects of the equipment.
Why Greater Noida?
Greater Noida’s strategic location, robust infrastructure, and supportive policies for industrial growth make it an ideal hub for manufacturing. The region’s proximity to New Delhi and excellent connectivity further enhance its appeal. LifeSaver Inc. Group has leveraged these advantages to establish a strong presence and cater to both domestic and international markets.
Conclusion
LifeSaver Inc. Group exemplifies how innovation and dedication can revolutionize the healthcare equipment manufacturing industry. By providing reliable and high-quality blood bank equipment, the company not only supports the critical operations of blood banks but also contributes to saving countless lives. For healthcare providers in Greater Noida and beyond, LifeSaver Inc. Group is a name synonymous with trust and excellence.
0 notes
Text
Advances in Patient Temperature Monitoring: Innovations and Technologies
The global patient temperature monitoring market size is expected to reach USD 5.85 Billion in 2030 and register a steady revenue CAGR of 6.4% during the forecast period, according to latest analysis by Emergen Research. Growing population as well as increasing occurrence of infectious diseases is a major factor driving market revenue growth. The world's population is expected to grow by over 2 billion individuals during the next 30 years, from 8 billion presently to 9.7 billion in 2050, with a peak of around 10.4 billion in the mid-2080s. Foodborne diseases, notably Campylobacteriosis, have a huge impact, hence approximately one in ten individuals fall ill each year and 33 million healthy life years are lost. During the course of many infectious diseases, body generates fever. As a result of growing worldwide population and prevalence infectious illnesses, there is a greater need for accurate patient temperature monitoring.
Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1576
Competitive Terrain:
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Patient Temperature Monitoring market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
Cardinal Health, Koninklijke Philips N.V., 3M, Drägerwerk AG & Co. KGaA, BD, OMRON Healthcare, Inc., Masimo, BRAUN GMBH Industrie-Elektronik, Terumo Corporation, and PAUL HARTMANN AG
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/patient-temperature-monitoring-market
Emergen Research has segmented the global Patient Temperature Monitoring market on the basis of type, application, end-use, and region:
Segments Covered in this report are:
Product Outlook (Revenue, USD Billion; 2019–2030)
Wearable Continuous Monitoring Sensors
Smart Temperature Monitoring Patches
Table-Top Temperature Monitoring Devices
Non–Invasive Vital Signs Monitoring Devices
Continuous Core Body Temperature Monitoring Devices
Handheld Temperature Monitoring Devices
Mercury Thermometers
Digital Thermometers
Infrared Thermometers
Invasive Temperature Monitoring Devices
Site Outlook (Revenue, USD Billion; 2019–2030)
Non-Invasive Temperature Monitoring Devices
Oral Temperature Monitoring
Axillary and Temporal Artery Temperature Monitoring
Tympanic Membrane Temperature Monitoring
Invasive Temperature Monitoring Devices
Esophageal Temperature Monitoring
Nasopharynx Temperature Monitoring
Urinary Bladder Temperature Monitoring
Rectal Temperature Monitoring
Application Outlook (Revenue, USD Billion; 2019–2030)
Pyrexia
Hypothermia
Blood Transfusion
Anesthesia
Other applications
The various regions analyzed in the report include:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
Analysis and estimation of the Patient Temperature Monitoring Market size and share for the projected period of 2022-2030
Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Patient Temperature Monitoring Market
Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1576
0 notes
Link
0 notes